Cylex IncorporatedCylex Incorporated.

Cylex IncorporatedCylex Incorporated, a life sciences company and leading tests in the function of the immune system, today announced results of a study on the effectiveness of the ImmuKnow to minimize risk of infection and rejection in patients after transplantation. Testing with ImmuKnow physicians can tailor immunosuppressant therapies to prevent rejection while avoiding infection.

1 transplantation Branch, NIDDK / NIH / DHHS, Bethesda, Nazih Zuhdi transplant Institute / Integris Health, Oklahoma City. Johns Hopkins Medical institutions in Baltimore, Starzl transplantation Institute, University of Pittsburgh, Pittsburgh, LifeLink Foundation, University of Texas Medical Branch in Galveston, University of California at Los Angeles, Fairfax, VA;.You of this report this report in the magazine Science.There which H5N1 avian flu ordinary virulence of virulent, the health experts worried.

Other articles from category "psychotherapy":

Random articles